Diagnostics,
Journal Year:
2020,
Volume and Issue:
10(6), P. 359 - 359
Published: May 30, 2020
The
objective
of
this
systematic
review
was
to
analyze
the
current
state
art
imaging-derived
biomarkers
predictive
genetic
alterations
and
immunotherapy
targets
in
lung
cancer.
We
included
original
research
studies
reporting
development
validation
imaging
feature-based
models.
overall
quality,
standard
advancements
towards
clinical
practice
were
assessed.
Eighteen
out
24
selected
articles
classified
as
"high-quality"
according
Quality
Assessment
Diagnostic
Accuracy
Studies
2
(QUADAS-2).
18
"high-quality
papers"
adhered
Transparent
Reporting
a
multivariable
prediction
model
for
Individual
Prognosis
or
Diagnosis
(TRIPOD)
with
mean
62.9%.
majority
(16/18)
phase
II.
most
commonly
used
predictors
radiomic
features,
followed
by
visual
qualitative
computed
tomography
(CT)
convolutional
neural
network-based
approaches
positron
emission
(PET)
parameters,
all
alone
combined
clinicopathologic
features.
(14/18)
focused
on
epidermal
growth
factor
receptor
(EGFR)
mutation.
Thirty-five
imaging-based
models
built
predict
EGFR
status.
model's
performances
ranged
from
weak
(n
=
5)
acceptable
11),
excellent
18)
outstanding
1)
set.
Positive
outcomes
also
reported
ALK
rearrangement,
ALK/ROS1/RET
fusions
programmed
cell
death
ligand
1
(PD-L1)
expression.
Despite
promising
results
terms
performance,
image-based
models,
suffering
methodological
bias,
require
further
before
replacing
traditional
molecular
pathology
testing.
Stroke,
Journal Year:
2024,
Volume and Issue:
55(5), P. 1428 - 1437
Published: April 22, 2024
Intracranial
aneurysms
(IAs)
remain
a
challenging
neurological
diagnosis
associated
with
significant
morbidity
and
mortality.
There
is
plethora
of
microsurgical
endovascular
techniques
for
the
treatment
both
ruptured
unruptured
aneurysms.
no
definitive
consensus
as
to
best
option
this
cerebrovascular
pathology.
The
Aneurysm,
Arteriovenous
Malformation,
Chronic
Subdural
Hematoma
Roundtable
Discussion
With
Industry
Stroke
Experts
discussed
practices
most
promising
approaches
improve
management
brain
Diagnostics,
Journal Year:
2020,
Volume and Issue:
10(6), P. 359 - 359
Published: May 30, 2020
The
objective
of
this
systematic
review
was
to
analyze
the
current
state
art
imaging-derived
biomarkers
predictive
genetic
alterations
and
immunotherapy
targets
in
lung
cancer.
We
included
original
research
studies
reporting
development
validation
imaging
feature-based
models.
overall
quality,
standard
advancements
towards
clinical
practice
were
assessed.
Eighteen
out
24
selected
articles
classified
as
"high-quality"
according
Quality
Assessment
Diagnostic
Accuracy
Studies
2
(QUADAS-2).
18
"high-quality
papers"
adhered
Transparent
Reporting
a
multivariable
prediction
model
for
Individual
Prognosis
or
Diagnosis
(TRIPOD)
with
mean
62.9%.
majority
(16/18)
phase
II.
most
commonly
used
predictors
radiomic
features,
followed
by
visual
qualitative
computed
tomography
(CT)
convolutional
neural
network-based
approaches
positron
emission
(PET)
parameters,
all
alone
combined
clinicopathologic
features.
(14/18)
focused
on
epidermal
growth
factor
receptor
(EGFR)
mutation.
Thirty-five
imaging-based
models
built
predict
EGFR
status.
model's
performances
ranged
from
weak
(n
=
5)
acceptable
11),
excellent
18)
outstanding
1)
set.
Positive
outcomes
also
reported
ALK
rearrangement,
ALK/ROS1/RET
fusions
programmed
cell
death
ligand
1
(PD-L1)
expression.
Despite
promising
results
terms
performance,
image-based
models,
suffering
methodological
bias,
require
further
before
replacing
traditional
molecular
pathology
testing.